CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Public ClinicalTrials.gov record NCT00707512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to determine the incidence and pattern of serious and/or clinically significant infections, malignancies, and other serious adverse event (SAE) in participants with Crohn's Disease (CD) treated with natalizumab. The secondary objective of this study in this study population is to evaluate disease severity over time in participants with CD treated with natalizumab based on changes in the Harvey-Bradshaw Index (HBI).
Study identification
- NCT ID
- NCT00707512
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2008 (Actual)
- Primary completion
- May 28, 2015 (Actual)
- Completion
- May 28, 2015 (Actual)
- Last update posted
- Jun 3, 2024
2008 – 2015
United States locations
- U.S. sites
- 35
- U.S. states
- 20
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research site | Scottsdale | Arizona | 85260 | — |
| Research site | Oceanside | California | 92056 | — |
| Research site | San Francisco | California | 94115 | — |
| Research site | Hamden | Connecticut | 06518 | — |
| Research site | Hartford | Connecticut | 06106 | — |
| Research site | Gainesville | Florida | 32610 | — |
| Research site | Miami | Florida | 33136 | — |
| Research site | Winter Park | Florida | 32789 | — |
| Research site | Atlanta | Georgia | 30342 | — |
| Research site | Crestview Hills | Kentucky | 41017 | — |
| Research site | Lexington | Kentucky | 40536 | — |
| Research site | Louisville | Kentucky | 40202 | — |
| Research site | Baltimore | Maryland | 21201 | — |
| Research site | Boston | Massachusetts | 02114 | — |
| Research site | Boston | Massachusetts | 02215 | — |
| Research site | Ann Arbor | Michigan | 48109 | — |
| Research site | Plymouth | Minnesota | 55446 | — |
| Research site | Columbia | Missouri | 65201 | — |
| Research site | Lebanon | New Hampshire | 03756 | — |
| Research site | Egg Harbor | New Jersey | 08234 | — |
| Research site | Great Neck | New York | 11021 | — |
| Research site | Lake Success | New York | 11042 | — |
| Research site | New York | New York | 10021 | — |
| Research site | Rochester | New York | 55905 | — |
| Research site | Troy | New York | 48084 | — |
| Research site | Chapel Hill | North Carolina | 27599 | — |
| Research site | Charlotte | North Carolina | 28207 | — |
| Research site | Raleigh | North Carolina | 27607 | — |
| Research site | Cincinnati | Ohio | 45219 | — |
| Research site | Cleveland | Ohio | 44195 | — |
| Research site | Providence | Rhode Island | 02904 | — |
| Research site | Nashville | Tennessee | 37232 | — |
| Research site | Grapevine | Texas | 76051 | — |
| Research site | Houston | Texas | 77030 | — |
| Research site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00707512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2024 · Synced Oct 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00707512 live on ClinicalTrials.gov.